NCT00190697View on ClinicalTrials.gov

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

April 30, 2007

Conditions

Breast CancerEndometrial CancerOvarian Cancer

Interventions

DRUG

arzoxifene

Trial Locations (1)

77030

For information regarding investigative sites for this clinical trial, call 1-877- CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or contact your personal physician, Houston

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00190697 - A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment | Biotech Hunter | Biotech Hunter